---
layout: report
type: weekly
topic_slug: chronic_migraine
topic_display: "Chronic Migraine"
week_start: 2025-08-25
week_end: 2025-08-31
permalink: /topics/chronic_migraine/weekly/2025-08-25/
source_run_ids:
  - chronic_migraine_20250826_091029
  - chronic_migraine_20250827_091408
  - chronic_migraine_20250828_091013
  - chronic_migraine_20250829_141515
  - chronic_migraine_20250830_090920
topics_covered:
  - Chronic Migraine
---

# Weekly Research Summary: Chronic Migraine

**Disclaimer:** This summary is generated by an AI assistant and is for informational purposes only. It is not a substitute for professional medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment.

---

### **TL;DR: Key Takeaways This Week**

-   New CGRP-targeted therapies, including monoclonal antibodies (mAbs), oral gepants, and nasal sprays, are significantly advancing chronic migraine prevention and acute treatment, offering more precise action and often safer alternatives for patients with cardiovascular concerns compared to older medications.
-   Consistent and detailed symptom tracking is crucial for all individuals with chronic migraine, from newly diagnosed patients to those managing long-term, as it helps identify triggers, optimize medication effectiveness, and guides informed discussions with healthcare providers.
-   Caregivers play a vital role in acute migraine management, from preparing personalized comfort kits to understanding the proper use of acute medications and recognizing critical red flags that necessitate emergency medical attention.

---

## Detailed Synthesis

This week's insights into chronic migraine emphasize a multi-faceted approach to management, highlighting the power of targeted therapies, the necessity of proactive symptom tracking, and the critical role of caregivers in supporting loved ones. A key theme emerging is the empowerment of patients and their support systems through education and collaboration with healthcare providers to achieve better quality of life.

### Revolutionizing Migraine Treatment: CGRP-Targeted Therapies

Significant advancements in chronic migraine treatment are centered around therapies that target the Calcitonin Gene-Related Peptide (CGRP) pathway. These innovative treatments offer a more precise approach to both preventing and acutely treating migraine attacks.

For **prevention**, CGRP monoclonal antibodies (mAbs) like Erenumab (Aimovig), Fremanezumab (Ajovy), Galcanezumab (Emgality), and Eptinezumab (Vyepti) have become game-changers. These are typically considered for patients with frequent migraines who haven't responded to traditional preventives. They work by blocking CGRP or its receptor, leading to a significant reduction in monthly migraine days for many, with fewer systemic side effects than older medications. Oral gepants, such as Atogepant (Qulipta) and Rimegepant (Nurtec ODT), also offer daily or every-other-day preventive options in pill form, providing flexibility and convenience.

For **acute treatment**, oral gepants like Ubrogepant (Ubrelvy) and Rimegepant (Nurtec ODT), along with the nasal spray Zavegepant (Zavzpret), offer rapid relief during an attack. These CGRP-targeted acute medications are particularly beneficial for individuals who experience severe nausea that prevents oral intake or those with cardiovascular risks, as they avoid the vasoconstrictive effects associated with triptans. While generally well-tolerated, common side effects across these therapies can include injection site reactions, constipation, nausea, and fatigue, which should always be discussed with a doctor.

### The Indispensable Role of Symptom Tracking

Across all stages of the migraine journey, from initial diagnosis to ongoing management, consistent and detailed symptom tracking stands out as an essential tool. For the **newly diagnosed**, tracking helps uncover unique migraine patterns, identify triggers like specific foods, stress, or sleep disruptions, and allows for early intervention, often improving medication effectiveness. By noting prodromal symptoms, individuals can take acute medication at the optimal time.

For **informed patients and caretakers**, a detailed migraine diary provides objective data on the frequency, severity, and duration of attacks, associated symptoms, and the effectiveness and side effects of both acute and preventive medications. This data is invaluable for productive discussions with neurologists, enabling personalized treatment adjustments and optimizing overall care. Tracking also helps monitor the impact of non-pharmacological strategies like stress management and regular sleep.

### Holistic Acute Attack Management and Caregiver Support

Managing acute migraine attacks effectively requires a combination of pharmacological and non-pharmacological strategies, with a significant role for caregivers. A **personalized migraine comfort kit**, curated by primary caretakers, can provide crucial sensory relief (e.g., weighted eye masks, noise-canceling headphones), non-pharmacological pain relief (topical gels, acupressure), and support hydration and gentle distraction during an attack. This kit supplements prescribed acute medications, enhancing comfort and recovery.

When it comes to **acute medications**, caretakers must understand the options and their proper use. Triptans remain effective but have limitations, including a risk of Medication Overuse Headache (MOH) if used too frequently (generally limited to 9 days/month) and contraindications for individuals with cardiovascular issues. Newer options like gepants and ditans (e.g., lasmiditan) offer alternatives, often with a safer cardiovascular profile and reduced MOH risk. Caretakers are advised to administer medication at the first sign of an attack, observe effectiveness, and strictly adhere to prescribed dosages.

Crucially, **emergency preparedness** is paramount. Caretakers must be vigilant for red flags that indicate a medical emergency rather than a typical migraine. Immediate medical attention (calling 911) is warranted for a sudden, severe "thunderclap" headache or abrupt, significant neurological changes (weakness, speech difficulties, unusual vision changes). Urgent evaluation in the ER is necessary for headaches accompanied by fever, stiff neck, rash, head trauma, new headaches in individuals over 50, or concerning changes in a usual migraine pattern. Trusting instincts and seeking prompt evaluation can be life-saving.

### Empowering Patients and Caregivers Through Informed Action

Ultimately, effective chronic migraine management is a collaborative effort. Patients are encouraged to be proactive by meticulously tracking their symptoms, understanding their treatment options, and preparing questions for their neurologists regarding medication choices, side effects, and expected outcomes. Caregivers, equipped with knowledge about acute management, comfort measures, and emergency signs, can provide invaluable support, significantly improving the quality of life for their loved ones. This informed partnership between patients, caregivers, and healthcare providers is key to navigating the complexities of chronic migraine.

**week_topics:**
- CGRP-targeted therapies
- Migraine prevention
- Acute migraine treatment
- Symptom tracking for migraine
- Caregiver support for migraine
- Migraine comfort kit
- Medication Overuse Headache (MOH)
- Migraine emergency signs
